Radiation Protection Challenges for a Human Mission to Mars

Abstract:

A human mission to Mars presents many challenges, not least of which is the radiation exposure that crew members will certainly receive in all phases of the journey, but most critically during the transits to and from Mars. Measurements from the Radiation Assessment Detector (RAD) aboard the Mars Science Laboratory Curiosity rover, made both in flight and on the surface of Mars, confirm previous estimates that crew members under reasonable shielding would receive a dose equivalent of about 1 Sievert on a 1000-day mission. In standard radiation biology, an acute exposure to 1 Sievert would be expected to increase lifetime fatal cancer risk by about 5%. This is well beyond the currently allowed 3% risk increase limit used by NASA and JAXA. Perhaps more significantly, the nature of exposure in space differs greatly from the terrestrial exposures that lead to the 5% estimate -- in space, the exposure is received at a very low dose rate, and includes a significant component from heavy ions in the Galactic Cosmic Rays (GCRs). Acute exposures to Solar Energetic Particles are also possible, but the generally lower energies of SEPs (kinetic energies typically below 100 MeV/nuc) mean that modest amounts of shielding are effective against them. Thus the greater concern for long-duration deep-space missions is the GCR exposure.

In this presentation, I will briefly review the MSL-RAD data and discuss current approaches to radiation risk estimation, including the NASA limit of 3% at the 95% confidence level. Recent results from the NASA radiation biology program indicate that cancer may not be the only risk that needs to be considered, with emerging concerns about cardiovascular and central nervous system health. These health effects are not accounted for in the current methodology and could potentially be threatening to mission success if they manifest in the course of the mission, rather than appearing many years after the exposure as radiation-induced cancer typically does.